Skip to content

Sufentanil as Adjuvant of Balanced Anesthesia

Comparison Between Sufentanil and Remifentanil as General Anesthetic Adjuvant

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03868111
Enrollment
66
Registered
2019-03-08
Start date
2019-11-04
Completion date
2020-01-12
Last updated
2020-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Brief summary

The aim of the study was to compare the efficacy and safety between sufentanil and remifentanil as an adjuvant of balanced general anesthesia.

Detailed description

The investigators hypothesized that sufentanil would reduce postoperative pain than remifentanil without prolonging recovery times in minor laparoscopic surgery when administered equivalent antinociceptive doses during surgery. Intraoperative opioid administration for equivalent nociception-antinociception balance could be achieved via surgical pleth index (SPI)-guided analgesia. This study was designed to compare the efficacy and safety between sufentanil and remifentanil as an adjuvant of balanced anesthesia in patients undergoing laparoscopic cholecystectomy under SPI-guided opioid administration.

Interventions

DRUGSufentanil

The infusion rate of sufentanil is adjusted to achieve a surgical pleth index of 20-50 throughout the operative time.

DRUGRemifentanil

The infusion rate of remifentanil is adjusted to achieve a surgical pleth index of 20-50 throughout the operative time.

Sponsors

Kangbuk Samsung Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Patients aged between 19 and 65 years * Patients with American Society of Anesthesiologists physical status I or II * Patients scheduled for elective laparoscopic cholecystectomy under balanced general anesthesia for benign cholecystic diseases * Patients obtaining written informed consent

Exclusion criteria

* Patients with asthma or hypertension * Patients with an inability to express their pain accurately * Patients with an inability to understand the pain scale * Patients with chronic abdominal pain or chronic pain syndrome * Patients who required to convert to laparotomy from laparoscopic surgery * Patients who required to receive incidental lower abdominal procedures owing to adhesion, injury, or other incidental findings at the lower abdominal cavity * Patients with a history of drug or alcohol abuse * Pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Postoperative wound pain score10 minutes after surgeryThe pain score is evaluated by 10 point visual analogue scale at post-anesthesia care unit. The visual analogue scale is presented as a 10-cm line with verbal descriptors indicating no pain and pain as bad as it could be. The visual analogue scale ranges from 0 to 10, representing minimum and maximum pain levels, respectively.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026